title: Primary vaginal adenocarcinoma arising in vaginal adenosis after CO2 laser vaporization and 5-fluorouracil therapy.
abstract: We present a case of a 45-year-old woman with a long-standing history of persistent cervical dysplasia that resulted in a hysterectomy. Subsequent vaginal smears revealed high-grade vaginal intraepithelial neoplasia (VAIN III) on Pap smear with positive human papilloma virus (HPV) testing. Over the course of 2 years, the patient underwent 2 CO(2) laser vaporization procedures of the upper vagina and intermittent 5-fluorouracil therapy. A biopsy performed at the time of the second laser procedure revealed endocervical-type well-differentiated adenocarcinoma, associated with VAIN III. HPV in situ hybridization for HPV types 16 and 18 was positive in both the glandular and squamous mucosa. The patient has no known history of intrauterine diethylstilbestrol exposure or mullerian developmental abnormalities. Subsequently, the patient underwent a radical upper vaginetcomy with bilateral pelvic lymph nodes dissection and bilateral salpingo-oophorectomy. The vaginectomy specimen showed residual adenocarcinoma associated with VAIN-III and extensive vaginal adenosis with free resection margins. This is the second reported case in the literature of adenocarcinoma arising in vaginal adenosis after 5-fluorouracil. Herein, we highlight these important findings and shed some light on the pathogenesis of vaginal adenosis and the subsequent development of vaginal adenocarcinoma.
authors.affiliation: Department of Pathology, State University of New York at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
authors.forename: Tamera A
authors.initials: TA
authors.lastname: Paczos
authors.forename: Stacey
authors.initials: S
authors.lastname: Ackers
authors.forename: Kunle
authors.initials: K
authors.lastname: Odunsi
authors.forename: Shashikant
authors.initials: S
authors.lastname: Lele
authors.forename: Paulette
authors.initials: P
authors.lastname: Mhawech-Fauceglia
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology* / Q000628:therapy / Q000821:virology; D001706:Biopsy; D002278:Carcinoma in Situ / Q000628:therapy; D004279:DNA, Viral / Q000737:chemistry / Q000235:genetics; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage* / Q000009:adverse effects; D006651:Histocytochemistry; D052162:Human papillomavirus 16 / Q000235:genetics; D052161:Human papillomavirus 18 / Q000235:genetics; D006801:Humans; D017403:In Situ Hybridization; D053685:Laser Therapy / Q000009:adverse effects / Q000379:methods*; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000473:pathology* / Q000821:virology; D014625:Vaginal Neoplasms / Q000473:pathology* / Q000628:therapy / Q000821:virology
chemical_list: D004279:DNA, Viral; D005472:Fluorouracil